Followers | 48 |
Posts | 11121 |
Boards Moderated | 0 |
Alias Born | 06/15/2014 |
Friday, April 05, 2024 11:05:15 AM
We should know relatively soon how this trial shapes up. UNCY, I am looking for at least a triple on good news.
Recent UNCY News
- Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference • GlobeNewswire Inc. • 04/10/2024 11:03:00 AM
- Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/28/2024 08:15:00 PM
- Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association Congress • GlobeNewswire Inc. • 03/25/2024 11:03:00 AM
- Unicycive Announces $50 Million Private Placement • GlobeNewswire Inc. • 03/14/2024 11:03:00 AM
- Unicycive Therapeutics Delivers Both an Oral and Poster Presentation on UNI-494 at the AKI and CRRT Conference • GlobeNewswire Inc. • 03/13/2024 11:03:00 AM
- Unicycive Therapeutics Completes Enrollment in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC) • GlobeNewswire Inc. • 03/07/2024 09:12:00 PM
- Unicycive Therapeutics Announces Orphan Drug Designation Granted for UNI-494 by the U.S. Food and Drug Administration for the Prevention of Delayed Graft Function in Kidney Transplant Patients • GlobeNewswire Inc. • 03/04/2024 12:03:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 09:06:09 PM
- Unicycive Therapeutics to Present Two Posters on Oxylanthanum Carbonate (OLC) at the Upcoming National Kidney Foundation Spring Clinical Meeting • GlobeNewswire Inc. • 02/14/2024 12:03:00 PM
- Unicycive Therapeutics Announces Both an Oral and Poster Presentation to be Delivered on UNI-494 at the Upcoming AKI and CRRT Conference • GlobeNewswire Inc. • 01/29/2024 12:03:00 PM
- Unicycive Therapeutics Issues Shareholder Letter to Highlight Corporate Progress and Key Upcoming Milestones • GlobeNewswire Inc. • 01/23/2024 12:03:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/22/2024 09:27:47 PM
- Unicycive Therapeutics Announces Enrollment of First Patient in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC) in Patients with Chronic Kidney Disease on Dialysis • GlobeNewswire Inc. • 12/18/2023 12:03:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 12/08/2023 09:36:22 PM
- Unicycive Therapeutics to Participate in Two Investor Conferences in December 2023 • GlobeNewswire Inc. • 11/29/2023 12:03:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 09:20:39 PM
- Unicycive Announces Third Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/14/2023 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 03:12:50 PM
- Unicycive Therapeutics Reaches Alignment with the FDA on Path to File New Drug Application for Oxylanthanum Carbonate (OLC) • GlobeNewswire Inc. • 10/23/2023 11:03:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:05:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/07/2023 08:33:22 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/07/2023 08:05:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2023 01:16:48 PM
- Unicycive Therapeutics Strengthens Board of Directors with Appointment of Sara Kenkare-Mitra, PhD • GlobeNewswire Inc. • 09/06/2023 11:03:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/31/2023 08:16:26 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM